Pharmaceutical Technology

JUNE 12, 2025

US Health Secretary Robert F Kennedy (RFK) Jr has appointed eight new members to the vaccine advisory panel at the Centers for Disease Control and Prevention (CDC), just days after firing the panel’s previous members in full. Can pharma tariffs “Make America Manufacture Again”? Credit: LightRocket via Getty Images. Who’s on the panel?

Vaccines 52

Vaccines Hospitals Communication Immunization 52

Pharmaceutical Technology

JUNE 20, 2025

Find out more This treatment involves obtaining immune cells from patients, modifying them in a laboratory setting then reintroducing them into patients’ bodies to destroy cancerous cells. Can pharma tariffs “Make America Manufacture Again”? Data Insights The gold standard of business intelligence.

Insurance Coverage and Processing 52

Insurance Coverage and Processing Hospitals Communication Pharmaceutical Manufacturing 52

Pharmaceutical Technology

JULY 4, 2025

How will RFK Jr’s American dream for vaccines play out? Go deeper with GlobalData Reports LOA and PTSR Model - Briquilimab in Severe Combined Immune Deficien. Nominate Now Share Copy Link Share on X Share on Linkedin Share on Facebook Go deeper with GlobalData Reports LOA and PTSR Model - Briquilimab in Severe Combined Immune Deficien.

Hospitals 52

Hospitals Packaging Communication Immunization 52

Pharmaceutical Technology

JUNE 11, 2025

CD4+T-cells and lymphocytes are both crucial elements of the immune system. Can pharma tariffs “Make America Manufacture Again”? Low levels of either increase the likelihood of infections and other health problems. HIV itself can reduce CD4 count – a value lower than 200 indicates acquired immunodeficiency syndrome (AIDS).

HIV Treatment and Prevention Agents 52

HIV Treatment and Prevention Agents Communication Hospitals Packaging 52

Pharmaceutical Technology

JULY 1, 2025

How will RFK Jr’s American dream for vaccines play out? The US Food and Drug Administration (FDA) has approved Takeda’s new immunoglobulin (IG) therapy, Gammagard liquid ERC [immune globulin infusion (human)], to treat primary immunodeficiency (PI) in individuals aged two years and above. Credit: HenadziPechan/Shutterstock.

Packaging 52

Packaging Communication Hospitals Drug Pricing 52

Pharmaceutical Technology

JULY 3, 2025

How will RFK Jr’s American dream for vaccines play out? It comes with one for cytokine release syndrome (CRS) and neurologic toxicity – including immune effector cell-associated neurotoxicity syndrome – in addition to warnings and precautions for infections, neutropenia, hepatotoxicity and embryo-foetal toxicity.

Packaging 52

Packaging Communication Hospitals Drug Pricing 52

Pharmaceutical Technology

JULY 1, 2025

How will RFK Jr’s American dream for vaccines play out? A preliminary look at the data from Capstan has revealed strong B-cell depletion – the aim of the treatment is to achieve an ‘immune reset’ by repopulation of healthy B cells. Investors shared positive sentiment in the acquisition, with shares in NYSE-listed AbbVie closing 1.7%

Insurance Coverage and Processing 52

Insurance Coverage and Processing Packaging Communication Hospitals 52

Pharmaceutical Technology

JUNE 16, 2025

A low incidence of immune effector cell-associated neurotoxicity syndrome was reported during the step-up dosing phase and the target dose phase. Can pharma tariffs “Make America Manufacture Again”? Two patients experienced dose-limiting toxicities and continued to receive the targeted dose.

Labelling 52

Labelling Communication Hospitals Vaccines 52

Pharmaceutical Technology

JUNE 18, 2025

By GlobalData Learn more about Strategic Intelligence FDA’s strategy on trial designs, vaccines and manufacturing Earlier this month, when the Department of Health and Human Sciences Secretary Robert Kennedy Jr. Can pharma tariffs “Make America Manufacture Again”?

Vaccines 52

Vaccines Communication Hospitals Drug Development 52

pharmaphorum

DECEMBER 23, 2022

In the last few years, the first generation of cell therapies has offered a powerful new way of treating blood cancers, with CAR-T technology reprogramming patients’ immune system to fight cancer. The post After a slow start for expensive CAR-T therapies, drug developers revisit oral therapies for blood cancer appeared first on.

Drug Development 52

Drug Development Immunization Immunity Hospitals 52

Pharma Mirror

OCTOBER 16, 2023

The first mRNA drug (BNT162b2 vaccine) was granted emergency use authorization by the FDA in December 2020 and approved for marketing in August 2021. The first mRNA drug (BNT162b2 vaccine) was granted emergency use authorization by the FDA in December 2020 and approved for marketing in August 2021.

Immunity 52

Immunity Immunization Vaccines 52

PharmaShots

MARCH 9, 2023

Birthplace: Belén was born in Almansa (Spain) Additional Information: Merck became a significant international participant in immunology, oncology, and immune oncology under her leadership of the Healthcare business. Designation: Global Head Previous company: Merck Global Vaccines (2 yrs. and Banco Bilbao Vizcaya Argentaria S.A

Clinical Pharmacology 40

Clinical Pharmacology Pharmaceutical Companies Immunization Pharmaceutical Companies 40

pharmaphorum

JANUARY 21, 2021

While restrictions on travel could prevent coronavirus transmission in the short term, digital passports showing COVID-negative and vaccination status may help reopen airports and other badly hit areas of the economy, reports Richard Staines. But could digital immunity passports be the answer?

Vaccines 85

Vaccines Immunization Immunity Hospitals 85

Pharmaceutical Technology

JULY 8, 2025

How will RFK Jr’s American dream for vaccines play out? Robert Barrie July 8, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The lawsuit marks the first legal challenge posited to RFK Jr and the HHS since his remodelling of vaccine regulation in the US.

Vaccines 75

Vaccines Packaging Communication Hospitals 75

Pharmaceutical Technology

JUNE 16, 2025

Keytruda is designed to enhance the immune system’s ability to detect and combat tumour cells. Can pharma tariffs “Make America Manufacture Again”? Based on these trial results, Keytruda as part of this regimen shows potential to change long-standing standards of care for treating certain patients with locally advanced HNSCC.”

Communication 52

Communication Research Laboratories Hospitals Vaccines 52

pharmaphorum

AUGUST 13, 2020

New York Magazine , the New York Times and The Economist amongst many other news organisations knocked down their paywalls for COVID-19-related coverage to keep readers informed in a rapidly changing and often confusing environment. Think you need to build manufacturing of a vaccine before you know what’s working.

Health and Personal Care Stores 112

Health and Personal Care Stores Vaccines Communication Pharmaceutical Companies 112

Pharmaceutical Technology

JUNE 13, 2025

Robert Barrie June 13, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook mRESVIA is the second approved product in the US for Moderna, along with its Covid-19 vaccine Spikevax. Until now, the vaccine was licensed for the prevention of lower respiratory tract disease (LRTD) caused by RSV in adults aged 60 years and older.

Vaccines 52

Vaccines Insurance Coverage and Processing Labelling Communication 52

pharmaphorum

SEPTEMBER 1, 2020

George Merck on the cover of Time magazine. In cancer, the pharma industry has begun producing immunotherapies, which do not act directly against the disease but instead enlist the immune system to fight against malignant tissues. Thalidomide and the development of drug safety regulation and monitoring.

Immunization 145

Immunization Immunity Diabetes Drug Development 145

Pharmaceutical Technology

JUNE 25, 2025

Scientific experts are concerned about what role vaccines will play in US public health strategy under the Trump administration. Robert Barrie June 25, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook RFK Jr has embarked on a mission to reset vaccine regulation and evidence generation in the US.

Vaccines 116

Vaccines Hospitals Packaging Communication 116

Pharmaceutical Technology

JUNE 10, 2025

Robert Barrie and Ross Law June 10, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The removal ACIP members marks the most significant upheaval to the current vaccine landscape under Trump’s administration. Can pharma tariffs “Make America Manufacture Again”? lev radin via Shutterstock. lev radin via Shutterstock.

Vaccines 52

Vaccines Insurance Coverage and Processing Drug Pricing Immunization 52

pharmaphorum

JULY 10, 2025

The new data from the US Measles Tracker , hosted by the International Vaccine Access Center (IVAC) at the Johns Hopkins Bloomberg School of Public Health, suggests that the US is at risk of losing its measles elimination status, according to IVAC executive director William Moss, who co-leads the tracking project.

Vaccines 64

Vaccines Diabetes Pharmaceutical Companies Pharmaceutical Companies 64